Skip to main content

Non-completion of latent tuberculous infection treatment among children in Rio de Janeiro State, Brazil

Buy Article:

$34.78 + tax (Refund Policy)

BACKGROUND: Children with latent tuberculous infection (LTBI) are particularly vulnerable to progression to active tuberculosis (TB), and are thus a priority target for isoniazid preventive therapy (IPT). However, adherence to IPT is poor. We hypothesised that children from poorer families, with reduced access to health care and lack of understanding about the disease are more likely to default from IPT.

METHODS: A questionnaire was administered to close child contacts or their parents at the time of prescribing IPT in three cities in Rio de Janeiro State. The children were followed prospectively. Treatment adherence was defined as taking 80% of prescribed doses.

RESULTS: Among 1078 children screened for LTBI, 97 (8.9%) did not return for tuberculin skin test (TST) reading; 332 (30.8%) were TST-positive; 115/332 (34.6%) were prescribed IPT, 6 of whom did not initiate treatment and 11 did not adhere during the first 2 months; 25 additional children did not complete IPT. Overall non-completion was four times more frequent among those with lower income. Health care access and knowledge did not improve treatment completion.

CONCLUSIONS: Substantial losses to follow-up occurred before IPT prescription; this should be further investigated. Among the children who started isoniazid, low income, but not difficult access or poor knowledge, increased the risk of treatment non-completion.

Keywords: LTBI; isoniazid; paediatrics; preventive therapy; tuberculosis

Document Type: Research Article

Affiliations: 1: *Federal University of Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil 2: Otago University, Dunedin, New Zealand 3: Souza Marques University, Rio de Janeiro, §Tuberculosis Scientific League, Rio de Janeiro, Rio de Janeiro, Brazil 4: §Tuberculosis Scientific League, Rio de Janeiro, Rio de Janeiro, Brazil 5: McGill University, Montreal, Quebec, Canada 6: *Federal University of Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil, §Tuberculosis Scientific League, Rio de Janeiro, Rio de Janeiro, Brazil, McGill University, Montreal, Quebec, Canada

Publication date: 01 April 2016

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.

    The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content